Jim Tananbaum Explores Innovative Solutions in Healthcare

Jim tananbaum is the chief executive officer of Foresite Capital. He founded Foresite as a healthcare private equity firm in 2011 specializing in addressing emerging healthcare needs. The company helps health care leaders achieve growth in profits by supplying networks, information, and capital.

Before founding the company, Jim Tananbaum founded GelTex Pharmaceuticals, which supplied drugs to the market at $80 million. GelTex Pharmaceuticals supplies Renagel, which has annual revenue of at least $1billion today. Besides, GelTex Mr. Tananbaum co-founded Theravance Inc and later became the CEO. The company shares GSK respiratory franchise via a joint venture INVA: NASDAQ, which has a total market capitalization of $3.2 billion.

Jim has much investment experience including being the founding partner of both Prospect Venture Partners III and II. Early in his healthcare career, he was a partner at Seira Ventures and oversaw the establishment of the healthcare services investment practice in the company. Jim Tananbaum has championed several investments such as Amira Pharmaceuticals. Jazz Pharmaceuticals, Healtheon and Amerigroup. His vision is to merge elements of different aspects in his career and create a leading and stable investment platform.

Mr. Jim Tananbaum is a graduate of Yale with a degree in computer science and electrical engineering. He holds an M.B.A and M.D from Harvard. He has an M.S from Massecheussetts Institute of Technology. He has been passionate about the interdisciplinary marriage between computer science, hard sciences, and healthcare. He has several long-term relationships with various leading academicians.

George Whitesides, Rick Klausner, Bob Gunderson, Rick Levin and Roy Vagelos are some of his mentors and collaborators. He has a strong passion in advancing his evolution work across different industries with lead academicians and entrepreneurs. Mr. Jim Tananbaum believes that to achieve great growth and change, better insights in science and deep learning is necessary.

According to Wired, Foresite Capital is a product of his long-standing career as an investment strategist and healthcare entrepreneur. Several factors played a major role in his success and transformation approach behind the innovation. Foresite Capital demonstrates his ability to harness and understand the future of healthcare. The insight is because of the recognition the need for capital in healthcare solutions and innovative products. The company plays a major role in defusing what is necessary for determining viable healthcare investment prospects with a high degree of success.